Peptide Synthesis Market
Healthcare Providers Innovate Advanced Oral Peptide Drugs to Treat Diabetes Patients. FMI Analyzes More Opportunities with the United States, China, Japan, and 30+ Countries.
Peptide Synthesis Market by Product and Services, Technology, End Use & Region | Forecast 2023 to 2033
An overview of the Peptide Synthesis Market
The peptide synthesis market is projected to secure a valuation of US$ 520.0 million in 2023 and is rising to US$ 1.1 billion by 2033. The market is predicted at a CAGR of 8% during the forecast period.
Peptide Synthesis Market – Driving Factors
- The rising number of pediatric patients, metabolic disorders, and growing demand for low-cost and effective drugs drive market growth.
- The adoption of peptide synthesis is rising due to high specificity, broad chemicals, low toxicity, and higher biological activity.
- The growing popularity of pharmacological components to develop medication is increasing the demand for peptide synthesis.
- Rising chronic diseases, including oncology, obesity, and diabetes, are expanding the market.
- The adoption of peptide synthesis is rising significantly for treating neurological illnesses and cardiovascular and renal failure.
Increasing Medication Issues Decline Market Growth
Rising chemical-produced medications and regulatory issues are the factors that may restrain market growth. The European Medicines Agency and Food and Drug Administration are also at odds in regulating the approval of medications based on the peptide. The lack of consistent rules and difficulty in permitting therapeutic peptides limit market growth.
How do Peptide Synthesis Manufacturers Drive Market Opportunities?
Advanced medicine and limited side effects increase the demand for peptide synthesis and market opportunities during the forecast period. The growing investment and key healthcare manufacturers pushing the investment in personalized medicine are driving market expansion. Growing technology of automated injection of various chemicals, such as membrane enhanced and ligand synthesis, is increasing the adoption of peptide synthesis.
Growing healthcare infrastructure and improvements in medications are boosting market opportunities. Manufacturers are advancing customized medicine, and individualized therapy for patients is further increasing market opportunities. The development of proteomic analysis and methods of determining molecular profiles greatly contribute to expanding the market growth.
The adoption of proteomics to clarify pathomechanisms illness is propelling the market size. The European Union scientist announced the development of user-friendly electrochemical customized peptide synthesis in the ElectroMed project, a technology to detect the interaction between immune receptors and short peptides. This customized peptide synthesis is typically based on a microfluidic multiplexing system.
|
Attributes |
Details |
|
Market CAGR (2023 to 2033) |
8% |
|
Market Valuation (2023) |
US$ 520 million |
|
Market Valuation (2033) |
US$ 1.1 billion |
Let us know your requirement to get
100% FREE customization
Peptide Synthesis Market, 2017 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook
According to Future Market Insights, the global peptide synthesis market is predicted at a healthy 8% CAGR during the forecast period. Historically, the market registered a CAGR of 11.5% between 2017 and 2022.
- Short Term (2023 to 2026): The increasing demand for peptide synthesis due to the growing metabolic disorders and low-cost treatments.
- Medium Term (2026 to 2029): The increasing biotech sector, advanced therapy, and investment in personalized medicine are driving market expansion.
- Long Term (2029 to 2033): Growing automated injection technology and the development of proteomics are increasing market opportunities.
The market is estimated to reach US$ 1.1 billion during the forecast period. Historically, the market stood at US$ 460.0 million from 2017 to 2022.
Comparative Analysis of Adjacent Markets
Peptide Synthesis Market:
|
Attributes |
Peptide Synthesis Market |
|
CAGR (2023 to 2033) |
8% |
|
Value (2023) |
US$ 520.0 million |
|
Value (2033) |
US$ 1.1 billion |
|
Trends |
The increasing biotech sector, advanced therapy, and investment in personalized medicine are driving market expansion. |
|
Opportunities |
Increasing automated injection technology and development of proteomics driving market opportunities. |
Peptide Therapeutics Market:
|
Attributes |
Peptide Therapeutics Market |
|
CAGR (2023 to 2033) |
8% |
|
Value (2023) |
US$ 40.49 billion |
|
Value (2033) |
US$ 87.41 billion |
|
Trends |
Growing demand for immune peptides and developed infrastructure. |
|
Opportunities |
Governments initiative, growing advanced therapy, and research and development activities. |
Custom Peptide Synthesis Services Market:
|
Attributes |
Custom Peptide Synthesis Services Market |
|
CAGR (2023 to 2033) |
7% |
|
Value (2023) |
US$ 571.41 million |
|
Value (2033) |
US$ 1,124.05 million |
|
Trends |
Growing research activities and investment in peptide synthesis. |
|
Opportunities |
Rising healthcare services and research activities to design drugs and vaccines |
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystTop Two Segments in the Market
| Segments | Product and Services |
| Top Category | Reagents |
| Historic CAGR | 11.4% |
| Forecast CAGR | 7.8% |
| Segments | End Use |
| Top Category | Pharmaceuticals & Biotechnology Companies |
| Historic CAGR | 11.1% |
| Forecast CAGR | 7.6% |
Which Category Leads the Product and Services Segment?
Based on the product and services segment, the reagents category holds a maximum CAGR of 7.8% during the forecast period. The adoption of reagents widely in laboratories, pharmaceutical manufacturing, and research & development activities is driving the market growth.
Apart from reagents, coupling agents are also widely used by various chemical laboratories to identify or research a particular substance. These growing demand factors are flourishing the market expansion. Historically, the reagents captured a CAGR of 11.4% between 2017 and 2022.
Which Category is Traced in the Technology Segment?
Based on technology, the segment is divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and membrane-enhanced peptide synthesis technology. Pharmaceuticals & biotechnology sectors use different technology to develop a certain product type. Therefore, chemical synthesis is the commonly used process for peptide production in these industries.
This process has influenced the adoption of enzymatic technology. Though, the changing environment and manufacturing caps on industries slow down the growth of this segment. The process of chemical synthesis triggers pollution and environmental risks.
Who is Leading the End Use Segment?
Based on end use, there are several industries like CDMOs & CROs, pharmaceuticals & biotechnology, academics & research institutions, and others. Pharmaceuticals and biotechnology are leading the segment by securing a CAGR of 7.6% during the forecast period. The adoption of peptide synthesis for the development of therapeutic in pharmaceuticals & biotechnology is bolstering the market growth.
The growing demand for drugs and vaccines with peptide synthesis is driving the pharmaceutical sector. For instance, AstraZeneca launched new advanced peptide therapy and next-generation medicine through research and development programs. FDA-approved Rybelsus tablets for diabetes type 2 patients. Historically, pharmaceuticals & biotechnology secured a CAGR of 11.1% between 2017 and 2020.
Top Countries Data Table Mentioned Below
| Countries | United States |
| CAGR (2017 to 2022) | 13.5% |
| CAGR (2023 to 2023) | 7.8% |
| Valuation (2023 to 2033) | US$ 398.6 million |
| Countries | United Kingdom |
| CAGR (2017 to 2022) | 12.5% |
| CAGR (2023 to 2023) | 7.1% |
| Valuation (2023 to 2033) | US$ 47.3 million |
| Countries | China |
| CAGR (2017 to 2022) | 13.1% |
| CAGR (2023 to 2023) | 7.4% |
| Valuation (2023 to 2033) | US$ 80.7 million |
| Countries | Japan |
| CAGR (2017 to 2022) | 12% |
| CAGR (2023 to 2023) | 6.5% |
| Valuation (2023 to 2033) | US$ 66 million |
| Countries | South Korea |
| CAGR (2017 to 2022) | 11.1% |
| CAGR (2023 to 2023) | 6% |
| Valuation (2023 to 2033) | US$ 39.6 million |
Growing Chronic Diseases Drive the United States Market
The United States dominates the global market by securing a CAGR of 7.8% with a valuation of US$ 398.6 million during the forecast period. The rise in chronic patients adopting peptide-based vaccines and drugs propels the United States market. In 2022, according to the American Cancer Society, around 1.9 million new cancer cases grew in the United States. Cancer is a prior deadly disease after a heart attack in the United States.
Increasing rates of diabetes patients, inactive lifestyles, and obesity are fueling the United States peptide synthesis market. In addition, the development of modern drugs and increasing government investment are expanding the United States market. Historically, the United States secured a CAGR of 13.5% between 2017 and 2022.
Research & Development Activities Upsurge the United Kingdom Market
The United Kingdom captured a CAGR of 7.1% with a valuation of US$ 47.3 million during the forecast period. Developing advanced chemical and organic peptides with a high investment in research and development activities is expanding the United States market. In addition, the growing risk of chronic diseases and the presence of the biochemical industry is surging the United States peptide synthesis market.
The rising urbanization, healthcare infrastructure, and manufacturing industry are expanding the market. Historically, the United Kingdom secured a CAGR of 12.5% between 2017 and 2020.
Increasing Biotech Industry Boosts China Market
China is contributing a CAGR of 7.4% with a valuation of US$ 80.7 million during the forecast period. Increasing research and development investment and the biotech sector are flourishing in China's peptide synthesis market growth. In addition, rising demand for the minimal cost of raw materials and the adoption of advanced therapy is further increasing the China market expansion.
Lack of proper diet, a sedentary lifestyle, and low physical activities result in chronic diseases, increasing the demand for peptide synthesis. Moreover, the present prominent players and the development of new technologies in peptide synthesis are driving China market. Historically, China secured a CAGR of 13.1% between 2017 and 2020.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
The multiple established companies and the presence of key players consolidate the market. In addition, due to the modernization of medical research and development projects and rising pharmaceutical manufacturing, the key competitors focus on providing effective products and services.
By adopting several marketing tactics and deep market research, the market players are increasing the sales of peptide synthesis products. Their marketing tactics are mergers, acquisitions, collaborations, and partnerships.
Recent Developments in the Market:
- On the recent Innovation of Greener Technology in slid-phase peptide synthesis, Novo Nordisk and Bachem Holding AG announced their partnership to replace N-dimethylformamide and reprotoxic.
- The United States-based Thermo Fisher Scientific has recently announced its biopharmaceutical research laboratories. These laboratories perform high throughput and liquid chromatography.
- In May 2022, Biohaven Pharmaceuticals and Pfizer Inc announced their agreement to manufacture advanced therapy for dual-acting migraine to treat patients and prevent episodic migraine.
- In May 2022, LOTTE Corporation acquired Bristol Myers to grow New York-based plant production by adopting novel biologics.
- In February 2022, Plexium and Amgen announced their collaboration to generate protein degradation therapeutics and molecular glue therapeutics.
Other Prominent Players Operating in the Market are
- GenScript Biotech Corporation
- Bachem Holding AG
- Thermo Fisher Scientific Inc
- Merck KGaA
- Kaneka Corporation
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2017 to 2022 |
|
Market Analysis |
US$ billion for Value |
|
Key Countries Covered |
United States, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, and Türkiye |
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Peptide Synthesis Market by Category
By Product and Services:
- Reagents
- Equipment
- Services
By Technology:
- Solid-phase peptide Synthesis
- Solution-phase Peptide Synthesis
- Hybrid & Recombinant Technology
By End Use:
- Pharmaceuticals & Biotechnology Companies
- CDMOs & CROs
- Academics & Research Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa (MEA)
Frequently Asked Questions
How is the Peptide Synthesis Market Growing?
The peptide synthesis market is predicted to expand at 8% CAGR through 2033.
What Drives the Peptide Synthesis Market?
The pharmaceutical sector drives the peptide synthesis market.
What is the Future Scope of Growth for the Peptide Synthesis Market?
The peptide synthesis market is expected to surpass US$ 1.1 billion by 2033.
What is the Peptide Synthesis Market Size?
The peptide synthesis market is anticipated to be US$ 520 million in 2023.
Which Country Leads the Peptide Synthesis Market?
The United States leads the peptide synthesis market.
Table of Content
1. Executive Summary | Peptide Synthesis Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product and Service, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product and Service, 2023 to 2033 5.3.1. Reagents 5.3.2. Equipment 5.3.3. Services 5.4. Y-o-Y Growth Trend Analysis By Product and Service, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product and Service, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 6.3.1. Solid-Phase Peptide Synthesis 6.3.2. Solution-Phase Peptide Synthesis 6.3.3. Hybrid & Recombinant Technology 6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End Use , 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use , 2023 to 2033 7.3.1. Pharmaceuticals & Biotechnology Companies 7.3.2. CDMOs & CROs 7.3.3. Academics & Research Institutes 7.4. Y-o-Y Growth Trend Analysis By End Use , 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End Use , 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product and Service 9.2.3. By Technology 9.2.4. By End Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product and Service 9.3.3. By Technology 9.3.4. By End Use 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product and Service 10.2.3. By Technology 10.2.4. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product and Service 10.3.3. By Technology 10.3.4. By End Use 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product and Service 11.2.3. By Technology 11.2.4. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product and Service 11.3.3. By Technology 11.3.4. By End Use 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Thailand 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. Rest of Asia Pacific 12.2.2. By Product and Service 12.2.3. By Technology 12.2.4. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product and Service 12.3.3. By Technology 12.3.4. By End Use 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Product and Service 13.2.3. By Technology 13.2.4. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product and Service 13.3.3. By Technology 13.3.4. By End Use 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product and Service 14.1.2.2. By Technology 14.1.2.3. By End Use 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product and Service 14.2.2.2. By Technology 14.2.2.3. By End Use 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product and Service 14.3.2.2. By Technology 14.3.2.3. By End Use 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product and Service 14.4.2.2. By Technology 14.4.2.3. By End Use 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product and Service 14.5.2.2. By Technology 14.5.2.3. By End Use 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product and Service 14.6.2.2. By Technology 14.6.2.3. By End Use 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product and Service 14.7.2.2. By Technology 14.7.2.3. By End Use 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product and Service 14.8.2.2. By Technology 14.8.2.3. By End Use 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product and Service 14.9.2.2. By Technology 14.9.2.3. By End Use 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product and Service 14.10.2.2. By Technology 14.10.2.3. By End Use 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product and Service 14.11.2.2. By Technology 14.11.2.3. By End Use 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product and Service 14.12.2.2. By Technology 14.12.2.3. By End Use 14.13. Thailand 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product and Service 14.13.2.2. By Technology 14.13.2.3. By End Use 14.14. Singapore 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product and Service 14.14.2.2. By Technology 14.14.2.3. By End Use 14.15. Australia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Product and Service 14.15.2.2. By Technology 14.15.2.3. By End Use 14.16. GCC Countries 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Product and Service 14.16.2.2. By Technology 14.16.2.3. By End Use 14.17. South Africa 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Product and Service 14.17.2.2. By Technology 14.17.2.3. By End Use 14.18. Israel 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Product and Service 14.18.2.2. By Technology 14.18.2.3. By End Use 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product and Service 15.3.3. By Technology 15.3.4. By End Use 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. GenScript Biotech Corporation 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Bachem Holding AG 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Thermo Fisher Scientific Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Merck KGaA 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Kaneka Corporation 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Biotage AB 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Syngene International Limited 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Mesa Laboratories, Inc. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Cem Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Proteogenix 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End Use , 2017 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End Use , 2017 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End Use , 2017 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by End Use , 2017 to 2033 Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 18: Asia Pacific Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 19: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 20: Asia Pacific Market Value (US$ Million) Forecast by End Use , 2017 to 2033 Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033 Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033 Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2017 to 2033 Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End Use , 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Technology, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End Use , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 17: Global Market Attractiveness by Product and Service, 2023 to 2033 Figure 18: Global Market Attractiveness by Technology, 2023 to 2033 Figure 19: Global Market Attractiveness by End Use , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Technology, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End Use , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 37: North America Market Attractiveness by Product and Service, 2023 to 2033 Figure 38: North America Market Attractiveness by Technology, 2023 to 2033 Figure 39: North America Market Attractiveness by End Use , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Technology, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End Use , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product and Service, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Technology, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End Use , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Technology, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by End Use , 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 77: Europe Market Attractiveness by Product and Service, 2023 to 2033 Figure 78: Europe Market Attractiveness by Technology, 2023 to 2033 Figure 79: Europe Market Attractiveness by End Use , 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Asia Pacific Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 82: Asia Pacific Market Value (US$ Million) by Technology, 2023 to 2033 Figure 83: Asia Pacific Market Value (US$ Million) by End Use , 2023 to 2033 Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 97: Asia Pacific Market Attractiveness by Product and Service, 2023 to 2033 Figure 98: Asia Pacific Market Attractiveness by Technology, 2023 to 2033 Figure 99: Asia Pacific Market Attractiveness by End Use , 2023 to 2033 Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033 Figure 101: Middle East and Africa Market Value (US$ Million) by Product and Service, 2023 to 2033 Figure 102: Middle East and Africa Market Value (US$ Million) by Technology, 2023 to 2033 Figure 103: Middle East and Africa Market Value (US$ Million) by End Use , 2023 to 2033 Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033 Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033 Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033 Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2017 to 2033 Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by End Use , 2017 to 2033 Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033 Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033 Figure 117: Middle East and Africa Market Attractiveness by Product and Service, 2023 to 2033 Figure 118: Middle East and Africa Market Attractiveness by Technology, 2023 to 2033 Figure 119: Middle East and Africa Market Attractiveness by End Use , 2023 to 2033 Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
